{"id":"https://openalex.org/W2045248178","doi":"https://doi.org/10.1007/s00262-003-0482-8","title":"Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors","display_name":"Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors","publication_year":2004,"publication_date":"2004-03-01","ids":{"openalex":"https://openalex.org/W2045248178","doi":"https://doi.org/10.1007/s00262-003-0482-8","mag":"2045248178","pmid":"https://pubmed.ncbi.nlm.nih.gov/14704833","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11034274"},"language":"en","primary_location":{"id":"doi:10.1007/s00262-003-0482-8","doi":"https://doi.org/10.1007/s00262-003-0482-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00262-003-0482-8","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11034274/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059562009","display_name":"Winfried S. Wels","orcid":"https://orcid.org/0000-0001-9858-3643","observed_orcids":["https://orcid.org/0000-0001-9858-3643"]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Winfried Wels","raw_affiliation_strings":["Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42-44, 60596, Frankfurt am Main, Germany. wels@em.uni-frankfurt.de","Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42-44, 60596, Frankfurt am Main, Germany. wels@em.uni-frankfurt.de","institution_ids":["https://openalex.org/I4210153469"]},{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210153469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045542767","display_name":"Markus Biburger","orcid":"https://orcid.org/0000-0002-9177-8402","observed_orcids":["https://orcid.org/0000-0002-9177-8402"]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Markus Biburger","raw_affiliation_strings":["Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Stra\u00dfe 42-44, 60596, Frankfurt am Main, Germany","Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Stra\u00dfe 42-44, 60596, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210153469"]},{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210153469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103475852","display_name":"Tina M\ufffdller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tina M\ufffdller","raw_affiliation_strings":["Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210153469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098168873","display_name":"Benjamin D\ufffdlken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Benjamin D\ufffdlken","raw_affiliation_strings":["Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210153469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5098065953","display_name":"Ulrike Gies\ufffdbel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulrike Gies\ufffdbel","raw_affiliation_strings":["Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210153469"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050893255","display_name":"Torsten Tonn","orcid":"https://orcid.org/0000-0001-9580-2193","observed_orcids":["https://orcid.org/0000-0001-9580-2193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Torsten Tonn","raw_affiliation_strings":["Institute for Transfusion Medicine and Immunohematology RCBDS, Frankfurt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Transfusion Medicine and Immunohematology RCBDS, Frankfurt, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061228788","display_name":"Christoph Uherek","orcid":"https://orcid.org/0000-0001-5579-6964","observed_orcids":["https://orcid.org/0000-0001-5579-6964"]},"institutions":[{"id":"https://openalex.org/I4210153469","display_name":"Georg Speyer Haus","ror":"https://ror.org/04xmnzw38","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210153469"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph Uherek","raw_affiliation_strings":["Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Stra\u00dfe 42-44, 60596, Frankfurt am Main, Germany","Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Paul-Ehrlich-Stra\u00dfe 42-44, 60596, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210153469"]},{"raw_affiliation_string":"Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210153469"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5059562009"],"corresponding_institution_ids":["https://openalex.org/I4210153469"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":null,"fwci":1.3803,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.7985044,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"53","issue":"3","first_page":"217","last_page":"226"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.07519999891519547,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/recombinant-immunotoxin","display_name":"recombinant immunotoxin","score":0.9459999799728394},{"id":"https://openalex.org/keywords/antibody-fragments","display_name":"antibody fragments","score":0.6489999890327454},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.8330000042915344},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.996999979019165},{"id":"https://openalex.org/keywords/gene-fusion","display_name":"gene fusion","score":0.4309999942779541},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.7099999785423279},{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9589999914169312},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.9679999947547913},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.5920000076293945},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.9632853269577026},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.8040382862091064},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.7001274824142456},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.6747442483901978},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5710675716400146},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4557090401649475},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4454093873500824},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.43667224049568176},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4241913855075836},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.36277279257774353},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30720922350883484},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3015759587287903},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1880720555782318},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08943724632263184},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08905550837516785}],"mesh":[{"descriptor_ui":"D000922","descriptor_name":"Immunotoxins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007128","descriptor_name":"Immunoglobulin Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018734","descriptor_name":"Genes, erbB-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00262-003-0482-8","doi":"https://doi.org/10.1007/s00262-003-0482-8","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00262-003-0482-8","pdf_url":null,"source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},{"id":"pmid:14704833","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14704833","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology, immunotherapy : CII","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11034274","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11034274/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunol Immunother","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11034274","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11034274/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunol Immunother","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W76522298","https://openalex.org/W1493661170","https://openalex.org/W1502247133","https://openalex.org/W1537158757","https://openalex.org/W1550092936","https://openalex.org/W1570699702","https://openalex.org/W1574443686","https://openalex.org/W1575477925","https://openalex.org/W1598843567","https://openalex.org/W1849770002","https://openalex.org/W1932544185","https://openalex.org/W1975097310","https://openalex.org/W1978185825","https://openalex.org/W1983056774","https://openalex.org/W1983111421","https://openalex.org/W2002708378","https://openalex.org/W2003052374","https://openalex.org/W2003572398","https://openalex.org/W2017019887","https://openalex.org/W2018238733","https://openalex.org/W2021714197","https://openalex.org/W2026057748","https://openalex.org/W2027815281","https://openalex.org/W2030077709","https://openalex.org/W2031154947","https://openalex.org/W2039943899","https://openalex.org/W2041623706","https://openalex.org/W2043830286","https://openalex.org/W2045117614","https://openalex.org/W2045852681","https://openalex.org/W2047205338","https://openalex.org/W2057458801","https://openalex.org/W2058753303","https://openalex.org/W2066565322","https://openalex.org/W2067109042","https://openalex.org/W2068602959","https://openalex.org/W2076526269","https://openalex.org/W2081298822","https://openalex.org/W2084186083","https://openalex.org/W2092796888","https://openalex.org/W2101883285","https://openalex.org/W2110099898","https://openalex.org/W2112041130","https://openalex.org/W2112628345","https://openalex.org/W2115759102","https://openalex.org/W2121870374","https://openalex.org/W2123206362","https://openalex.org/W2139816948","https://openalex.org/W2143562065","https://openalex.org/W2159542715","https://openalex.org/W2160989461","https://openalex.org/W2166487857","https://openalex.org/W2172583254","https://openalex.org/W2228278800","https://openalex.org/W2314166141","https://openalex.org/W2335889607","https://openalex.org/W2406035635","https://openalex.org/W2413087295","https://openalex.org/W4313341443"],"related_works":["https://openalex.org/W1541033317","https://openalex.org/W2009013652","https://openalex.org/W1578295922","https://openalex.org/W4244890684","https://openalex.org/W2042049311","https://openalex.org/W1984307785","https://openalex.org/W180718913","https://openalex.org/W116850897","https://openalex.org/W2063576898","https://openalex.org/W2049864550"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}